Last reviewed · How we verify

NCT04062812

New Protocol With Diluted Citrate in Continuous Techniques

Completed NA Last updated 12 January 2024
What this trial tests

NA trial testing the same citrate dosification in both types in Acute Renal Failure in 66 participants. Completed in 20 December 2021.

Timeline
1 August 2019
Primary endpoint
1 October 2021
20 December 2021

Quick facts

Lead sponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsequential
Maskingsingle
Primary purposetreatment
Enrollment66
Start date1 August 2019
Primary completion1 October 2021
Estimated completion20 December 2021
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Who can join

18 and older, any sex, with Acute Renal Failure or Dialysis; Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators designed a monitoring and control table of a citrate treatment on a specific monitor. This is the Baxter "Prismaflex" monitor, with 8.2 software version. Dialysis bath liquids marketed by Baxter: Biphozyl are used. Citrate liquid (1:18) Regiocit is used. The dialysis treatment monitor (CVVHD) is programmed, with a blood / citrate pumps at a rate of 1:10 (1 ml / min of blood: 10 ml / h of dialysis fluid) The starting dose of citrate will be 3.5 mmol / l and the calcium compensation will be 100% Working hypothesis: The patient undergoing citrate anticoagulation according to the designed algorithm will respond with ion stability and pH during the treatment, in addition to achieving an effective cleaning process.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Acute Renal Failure

Currently open trials in the same condition.

Other Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04062812.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing